Analytical flow cytometry is an essential technology for all of the investigators participating in this program project. This flow cytometry core will augment existing capabilities at our institution by providing the first flow cytometer to be housed and operated in our Biosafety Level 3 laboratories. Funds for the purchase of this instrument have already been committed by the institution, and we anticipate the purchase and installation of a Becton-Dickinson FACSCalibur analyzer with low speed sorting capability before the initiation of this program grant. This instrument will allow the performance of up to four color fluoresence single cell analysis of cell suspensions harvested from mice infected with virulent or potentially virulent strains of M. tuberculosis. Multicolor FACS analyses using a range of monoclonal antibodies to identify and quantitate specific cell populations will be carried out routinely by this facility, as will staining of specific T cell populations using peptide loaded MHC class I tetramer reagents. Analysis of apoptosis, cell cycle progression and calcium flux will also be available in a BSL-3 environment through the establishment of this core. Limited cell sorting capabilities that should be adequate for the proposed isolation of serologically modified mutants of M. tuberculosis will also by possible with this core facility. The core director, Dr. Steven Porcelli, was first trained in the use of analytical flow cytometers in 1989, and has been actively using these instruments in his own research continuously since that time. He also is currently the director of the flow cytometry facility of the NIH funded AECOM Center for Aids Research, which provides a BSL-2 environment for analytical flow cytometry as well as limited sorting capability using a Becton-Dickinson FACSort instrument. He is experienced in training and supervisingtechnicians and other laboratory personnel to carry out flow cytometry procedures. In establishing this core facility, he will recruit and train an appropriate individual to serve as a dedicated flow cytometry technician to carry out the bulk of the day to day operation of the core.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI063537-04
Application #
7599638
Study Section
Special Emphasis Panel (ZAI1)
Project Start
2008-04-01
Project End
2010-03-31
Budget Start
2008-04-01
Budget End
2009-03-31
Support Year
4
Fiscal Year
2008
Total Cost
$134,418
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Type
DUNS #
110521739
City
Bronx
State
NY
Country
United States
Zip Code
10461
Harbut, Michael B; Yang, Baiyuan; Liu, Renhe et al. (2018) Small Molecules Targeting Mycobacterium tuberculosis Type II NADH Dehydrogenase Exhibit Antimycobacterial Activity. Angew Chem Int Ed Engl 57:3478-3482
Kunnath-Velayudhan, Shajo; Goldberg, Michael F; Saini, Neeraj K et al. (2017) Transcriptome Analysis of Mycobacteria-Specific CD4+ T Cells Identified by Activation-Induced Expression of CD154. J Immunol 199:2596-2606
Glass, Lisa N; Swapna, Ganduri; Chavadi, Sivagami Sundaram et al. (2017) Mycobacterium tuberculosis universal stress protein Rv2623 interacts with the putative ATP binding cassette (ABC) transporter Rv1747 to regulate mycobacterial growth. PLoS Pathog 13:e1006515
Johnson, Alison J; Kennedy, Steven C; Lindestam Arlehamn, Cecilia S et al. (2017) Identification of Mycobacterial RplJ/L10 and RpsA/S1 Proteins as Novel Targets for CD4+ T Cells. Infect Immun 85:
Phuah, Jiayao; Wong, Eileen A; Gideon, Hannah P et al. (2016) Effects of B Cell Depletion on Early Mycobacterium tuberculosis Infection in Cynomolgus Macaques. Infect Immun 84:1301-1311
Carreño, Leandro J; Saavedra-Ávila, Noemí A; Porcelli, Steven A (2016) Synthetic glycolipid activators of natural killer T cells as immunotherapeutic agents. Clin Transl Immunology 5:e69
Foreman, Taylor W; Mehra, Smriti; LoBato, Denae N et al. (2016) CD4+ T-cell-independent mechanisms suppress reactivation of latent tuberculosis in a macaque model of HIV coinfection. Proc Natl Acad Sci U S A 113:E5636-44
Vergnolle, Olivia; Xu, Hua; Tufariello, JoAnn M et al. (2016) Post-translational Acetylation of MbtA Modulates Mycobacterial Siderophore Biosynthesis. J Biol Chem 291:22315-22326
Olsen, Aaron; Chen, Yong; Ji, Qingzhou et al. (2016) Targeting Mycobacterium tuberculosis Tumor Necrosis Factor Alpha-Downregulating Genes for the Development of Antituberculous Vaccines. MBio 7:
Prados-Rosales, Rafael; Carreño, Leandro J; Weinrick, Brian et al. (2016) The Type of Growth Medium Affects the Presence of a Mycobacterial Capsule and Is Associated With Differences in Protective Efficacy of BCG Vaccination Against Mycobacterium tuberculosis. J Infect Dis 214:426-37

Showing the most recent 10 out of 64 publications